ProAir HFA FDA Approval History
FDA Approved: Yes (First approved October 29, 2004)
Brand name: ProAir HFA
Generic name: albuterol sulfate
Dosage form: Inhalation Aerosol
Company: Teva Pharmaceutical Industries Ltd.
Treatment for: Asthma
ProAir HFA (albuterol sulfate) inhalation aerosol is a beta2-adrenergic agonist indicated for treatment or prevention of bronchospasm.
Development timeline for ProAir HFA
|Sep 24, 2008||Approval Teva's ProAir HFA, the Market Leading Albuterol Inhaler, Receives New Pediatric Indication|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.